Candidate shows statistically significant dose-dependent effects on biomarkers, supporting further development.
Company is focused on endocrine disorders. Deal led by Perceptive Advisors.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Synlogic Inc is a biopharmaceutical company focused on advancing the drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer.
| Website: | www.synlogictx.com |
| Email: | liz@synlogictx.com |
| Main Phone: | +1 617 401-9975 |
| Address: | 301 Binney Street |
| Address 2: | Suite 402 |
| State: | MA |
| City / Town: | Cambridge |
| Country: | US |
| Postal Code: | 02142 |
| Exchange: | NSD |
| CEO: | Aoife M. Brennan |
| Employees: | 72 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Candidate shows statistically significant dose-dependent effects on biomarkers, supporting further development.
Company is focused on endocrine disorders. Deal led by Perceptive Advisors.
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
